NO913136L - Fremgangsmaate for fremstilling av et preparat for oeyedraaper - Google Patents

Fremgangsmaate for fremstilling av et preparat for oeyedraaper

Info

Publication number
NO913136L
NO913136L NO91913136A NO913136A NO913136L NO 913136 L NO913136 L NO 913136L NO 91913136 A NO91913136 A NO 91913136A NO 913136 A NO913136 A NO 913136A NO 913136 L NO913136 L NO 913136L
Authority
NO
Norway
Prior art keywords
preparation
procedure
eye drill
eye
drill
Prior art date
Application number
NO91913136A
Other languages
English (en)
Other versions
NO177845B (no
NO177845C (no
NO913136D0 (no
Inventor
Kazumichi Ushio
Yoshifumi Ikejiri
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of NO913136D0 publication Critical patent/NO913136D0/no
Publication of NO913136L publication Critical patent/NO913136L/no
Publication of NO177845B publication Critical patent/NO177845B/no
Publication of NO177845C publication Critical patent/NO177845C/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
NO913136A 1990-08-13 1991-08-12 Fremgangsmåte for fremstilling av et preparat for öyedråper NO177845C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21482790 1990-08-13
JP16285491 1991-07-03

Publications (4)

Publication Number Publication Date
NO913136D0 NO913136D0 (no) 1991-08-12
NO913136L true NO913136L (no) 1992-02-14
NO177845B NO177845B (no) 1995-08-28
NO177845C NO177845C (no) 1995-12-06

Family

ID=26488494

Family Applications (1)

Application Number Title Priority Date Filing Date
NO913136A NO177845C (no) 1990-08-13 1991-08-12 Fremgangsmåte for fremstilling av et preparat for öyedråper

Country Status (16)

Country Link
US (1) US5663170A (no)
EP (1) EP0472327B1 (no)
JP (1) JP2769253B2 (no)
KR (1) KR920003971A (no)
AT (1) ATE121295T1 (no)
AU (1) AU633754B2 (no)
CA (1) CA2048942A1 (no)
DE (1) DE69109021T2 (no)
DK (1) DK0472327T3 (no)
ES (1) ES2071227T3 (no)
FI (1) FI97777C (no)
HU (1) HU207950B (no)
NO (1) NO177845C (no)
PT (1) PT98643B (no)
RU (1) RU2068260C1 (no)
TW (1) TW200402B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018764A2 (en) * 1992-03-18 1993-09-30 Coopervision Pharmaceuticals, Inc. VERAPAMIL HCl FORMULATION AND OTHER OPHTHALMIC SOLUTIONS WITH BUFFER SYSTEM FOR OCULAR ADMINISTRATION
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
WO1994010976A1 (en) * 1992-11-16 1994-05-26 Ciba Vision Ag, Hettlingen Polyvinyl alcohol/borate ophthalmic drug delivery system
US5494901A (en) * 1993-01-05 1996-02-27 Javitt; Jonathan C. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
SE501482C2 (sv) * 1993-06-24 1995-02-27 Leiras Oy Komposition för topisk administration av bispilokarpinsyradiestrar till ögat i form av en vattenlösning
EP0711147A1 (en) * 1993-07-28 1996-05-15 Insite Vision Incorporated Suspensions for delivery of medicament
US5977180A (en) * 1994-07-11 1999-11-02 Pate; David W. Anandamide analog compositions and method of treating intraocular hypertension using same
US5631297A (en) * 1994-07-11 1997-05-20 Pate; David W. Anandamides useful for the treatment of intraocular hypertension, ophthalmic compositions containing the same and methods of use of the same
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
KR100261585B1 (ko) * 1995-01-20 2000-07-15 오쿠다 기요아키 항염증점안제
ATE215821T1 (de) * 1995-01-20 2002-04-15 Wakamoto Pharma Co Ltd Entzündungshemmende augentropfen
US6476004B1 (en) 1996-07-18 2002-11-05 Mitsubishi Pharma Corporation Pharmaceutical composition
JP2002241272A (ja) * 1996-07-18 2002-08-28 Mitsubishi Pharma Corp 医薬処方組成物
JPH11209277A (ja) * 1998-01-19 1999-08-03 Yoshitomi Pharmaceut Ind Ltd 医薬組成物
GB9711643D0 (en) * 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
JP2002523475A (ja) * 1998-09-02 2002-07-30 アラーガン・セイルズ・インコーポレイテッド 防腐したシクロデキストリン含有組成物
JP2001125052A (ja) * 1999-10-25 2001-05-11 Lion Corp コンタクトレンズ装着液
ATE324910T1 (de) * 2000-06-19 2006-06-15 Santen Pharmaceutical Co Ltd Aseptische mittel
US6468989B1 (en) 2000-07-13 2002-10-22 Dow Pharmaceutical Sciences Gel compositions containing metronidazole
US6881726B2 (en) 2001-12-24 2005-04-19 Dow Pharmaceutical Sciences Aqueous compositions containing metronidazole
WO2006137433A1 (ja) * 2005-06-21 2006-12-28 Wakamoto Pharmaceutical Co., Ltd. レボカバスチンを可溶化させた水性薬剤
US20100069335A1 (en) * 2005-07-15 2010-03-18 Rajiv Bhushan Prevention and Treatment of Ophthalmic Complications of Diabetes
TR201820073T4 (tr) 2012-03-26 2019-01-21 Santen Pharmaceutical Co Ltd Diquafosol içeren göz damlası.
TW202014194A (zh) * 2018-04-27 2020-04-16 美商歐樂根公司 抗微生物功效增強且毒性降低之亞氯酸鈉組成物
KR102266014B1 (ko) * 2019-11-21 2021-06-17 삼진제약주식회사 안질환 예방 또는 치료용 점안 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU602641B2 (en) * 1986-04-17 1990-10-18 Senju Pharmaceutical Co., Ltd. Thiolactam-N-acetic acid derivatives, their production and use

Also Published As

Publication number Publication date
ES2071227T3 (es) 1995-06-16
JPH05213757A (ja) 1993-08-24
PT98643A (pt) 1992-07-31
TW200402B (no) 1993-02-21
DK0472327T3 (da) 1995-05-08
US5663170A (en) 1997-09-02
FI97777B (fi) 1996-11-15
NO177845B (no) 1995-08-28
EP0472327B1 (en) 1995-04-19
KR920003971A (ko) 1992-03-27
FI97777C (fi) 1997-02-25
JP2769253B2 (ja) 1998-06-25
ATE121295T1 (de) 1995-05-15
PT98643B (pt) 1999-01-29
FI913811A (fi) 1992-02-14
DE69109021D1 (de) 1995-05-24
FI913811A0 (fi) 1991-08-12
EP0472327A1 (en) 1992-02-26
NO177845C (no) 1995-12-06
RU2068260C1 (ru) 1996-10-27
AU8170891A (en) 1992-02-20
CA2048942A1 (en) 1992-02-14
DE69109021T2 (de) 1995-09-21
NO913136D0 (no) 1991-08-12
HUT61196A (en) 1992-12-28
HU207950B (en) 1993-07-28
HU912692D0 (en) 1992-01-28
AU633754B2 (en) 1993-02-04

Similar Documents

Publication Publication Date Title
NO913136L (no) Fremgangsmaate for fremstilling av et preparat for oeyedraaper
NO912630D0 (no) Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler.
NO914115D0 (no) Fremgangsmaate for fremstilling av peroksidiske perfluorpolyetere
PL309812A1 (en) Derivatives of 2-(2-amino- 1,6-dihydro-6-oxopurin-9-ylo) - methoxy-1,3-propanodiole, method of obtaining them and pharmaceutical composition containing such derivatives
NO179612C (no) Analogifremgangsmåte for fremstilling av 3-arylkarbonyl-1-aminoalkyl-1H-indol-forbindelser
NO175976C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
DE69231883T2 (de) 4-(1,1-Dialkoxycarbonyl-Alkyl)Azetidin-2-on-Derivate zur Herstellung von 4-(1-Carboxy-Alkyl)Azetidin-2-on-Derivaten
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
ATE359997T1 (de) Guanidinomethylcyclohexancarbonsäure-ester derivate
PT97663A (pt) Processo de preparacao de 3'-desamino-4'-desoxi-4'-amino-8-fluoro-antraciclinas, de composicoes farmaceuticas que as contem e de seus intermediarios
NO912636L (no) Fremgangsmaate for fremstilling av svovelsubstituerte mevininsyre-derivater.
IE840831L (en) 1,4-dihydropyridine derivatives
BR8801794A (pt) Composicao fungicida e processo para a preparacao de derivados de 2-(o-alquila/substituido/)-2-tio-1,3,2-oxatiofosfolano
HU202246B (en) Fungicide compositions containing 2-(substituted)-aryl- or aryloxy- or arylthio-(alkyl- or alkoxy)-2-thio-1,3,2-oxathio-phospholane derivatives as active components and process for producing the active components
NO172492C (no) Fremgangsmaate for fremstilling av alkalimetall- eller jordalkalimetallsalter av n5-formyl-5,6,7,8-tetrahydrofolsyre
FI941850A0 (fi) Uusi yhdiste, joka on leustroduksiini H, sen valmistus ja terapeuttinen käyttö
WO1994012483A3 (de) Thiocyanatomethylthiobenzthiazol-derivate
NO922253L (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater
NO922254L (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater